The effect of stress on the onset and progression of Creutzfeldt-Jakob disease: Results of a German pilot case-control study

European Journal of Epidemiology

Volumn 15, Issue 7, 1999, Pages 631-635

  Laske, C ^b   Gefeller, Olaf ^a   Pfahlberg, A ^b   Zerr, I ^b   Schroter A ^b   Poser, S ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b NONE

Author keywords

Case control study; Creutzfeldt Jakob disease; Neuroepidemiology; Stress

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE COURSE; FEMALE; GERMANY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIFE EVENT; MALE; PATHOPHYSIOLOGY; STRESS; STROKE; VERTIGO;

AGE DISTRIBUTION; AGE OF ONSET; AGED; CASE-CONTROL STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; CREUTZFELDT-JAKOB SYNDROME; DISEASE PROGRESSION; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PILOT PROJECTS; REFERENCE VALUES; RISK ASSESSMENT; SEX DISTRIBUTION; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 0032828657     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007683208121     Document Type: Article

References (18)

1. Alperovitch A, Brown P, Weber T, Pocchiary M, Hofman A, Will RG. The incidence of Creutzfeldt-Jakob disease in Europe in 1993. Lancet 1994; 334: 918.
2. Zerr I, Bodemer M, Räcker S, Grosche S, Poser S, Kretzschmar HA, et al. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 1995; 345: 1609-1610.
3. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996; 335: 924-930.
4. Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998; 43: 32-40.
5. Wientjens DP, Davanipour Z, Hofman A, Kondo K, Matthews WB, Will RG, et al. Risk factors for Creutzfeldt-Jakob disease: A reanalysis of case-control studies. Neurology 1996; 46: 1287-1291.
6. van Duijn CM, Delasnerie-Laupretre N, Masullo C, Zerr I, de Silva R, Wientjens DPWM, Brandel J-P, Weber T, Bonavita V, Zeidler M, Alperovitch A, Poser S, Granieri E, Hofman A, Will RG. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-1995. Lancet 1998; 351: 1081-1085.
7. Masters CL, Harris JO, Gajdusek DC, Gibbs CJ Jr., Bernoulli C and Asher DM. Creutzfeldt-Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979; 5: 177-188.
8. Will RG. Epidemiology of Creutzfeldt-Jakob disease. Br Med Bull 1993; 49: 960-970.
9. Breslow NE, Day NE. Statistical methods in cancer research. Vol. I: The analysis of case-control data. Lyon: IARC Publications, 1980.
10. Kopec JA, Esdaile JM. Bias in case-control studies. A review. J Epidemiol Comm Health 1990; 44: 179-186.
11. Brandel J-P, Delasnerie-Laupretre N. Creutzfeldt-Jakob disease and stress. Journal of Neurology, Neuro-surgery, and Psychiatry 1997; 62: 541.
12. Kondo K, Kuroiwa Y. A case-control study of Creutzfeldt-Jakob disease: Association with physical injuries. Ann Neurol 1982; 11: 377-381.
13. Behl C, Lezoualc'h F, Trapp T, Widmann M, Skutella T, Holsboer F. Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology 1997; 138 (1): 101-106.
14. Relton JK, Rothwell NJ. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull 1992; 29 (2): 243-246.
15. Gadient RA, Otten UH. Interleukin-6 (IL-6)- a molecule with both beneficial and destructive potentials. Prog Neurobiol 1997; 52 (5): 379-390.
16. Kordek R, Nerurkar VR, Liberski PP, Isaacson S, Yanagihara R, Gajdusek DC. Heightened expression of tumor necrosis factor alpha, interleukin 1 alpha, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice. Proc Natl Acad Sci USA 1996; 93 (18): 9754-9758.
17. Folnegovic-Smalc V. Psychotrauma related to war and exile as a risk factor for the development of dementia of Alzheimer's type in refugees. Croatian Medical Journal 1997; 38: 273-276.
18. Hull M, Strauss S, Berger M, Volk B, Bauer J. The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease. Behav Brain Res 1996; 78 (1): 37-41.